Markets:

Overview

News

Currencies

International

Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

72.82 -1.65 (-2.22%)

Streaming Delayed Price Updated: 3:15 PM EDT, Mar 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

22 23 Next >

For those who appreciate growth without the sticker shock, LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is worth considering. ↗

March 15, 2025

Discover LANTHEUS HOLDINGS INC, an undervalued growth gem. NASDAQ:LNTH is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing...

Via Chartmill

Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks

March 10, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including Lantheus (NASDAQ:LNTH) and its...

Via StockStory

Topics Artificial Intelligence

ResMed Among Top Stocks For Recent And Long-Term Profit Growth ↗

March 10, 2025

A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue?

Via Investor's Business Daily

3 Growth Stocks to Stash

March 07, 2025

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s...

Via StockStory

Lantheus' Pylarify Hit $1B in 2024 Sales ↗

February 27, 2025

Via The Motley Fool

Earnings Scheduled For February 26, 2025 ↗

February 26, 2025

Via Benzinga

Lantheus (LNTH): A 10x Opportunity in Radiopharmaceuticals ↗

February 25, 2025

Via The Motley Fool

What 4 Analyst Ratings Have To Say About Lantheus Holdings ↗

January 14, 2025

Via Benzinga

Root And ZoomInfo Are Among Top 8 Mid-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio? ↗

March 02, 2025

Top mid-cap stock gainers in past week: Root, Bridge Investment Group, Huron Consulting, Medical Properties Trust, ZoomInfo Technologies, Lantheus Holdings, Alignment Healthcare, VSE. Analysts raise...

Via Benzinga

Workday, ACM Research, ZoomInfo Technologies, CEVA, Intuit And Other Big Stocks Moving Higher On Wednesday ↗

February 26, 2025

Via Benzinga

Lantheus (LNTH) Shares Skyrocket, What You Need To Know

February 26, 2025

Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) jumped 19.8% in the morning session after the company delivered strong fourth-quarter 2024 results, with revenue and earnings...

Via StockStory

Why Lantheus Holdings (LNTH) Stock Is Down 4% ↗

January 13, 2025

Lantheus shares are trading lower by 5.4% during Monday's session. The company announced a $350 million acquisition.

Via Benzinga

Lantheus’s (NASDAQ:LNTH) Q4 Sales Top Estimates, Stock Soars

February 26, 2025

Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 10.5% year on year to $391.1 million. On the other hand,...

Via StockStory

Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance

February 26, 2025

From Lantheus Holdings, Inc.

Via GlobeNewswire

Earnings To Watch: Lantheus (LNTH) Reports Q4 Results Tomorrow

February 25, 2025

Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings tomorrow before market hours. Here’s what you need to know.

Via StockStory

NASDAQ:LNTH is not too expensive for the growth it is showing. ↗

February 21, 2025

LANTHEUS HOLDINGS INC was identified as a growth stock that isn't overvalued. NASDAQ:LNTH is excelling in various growth indicators while maintaining a solid financial footing.

Via Chartmill

Lantheus to Present at Upcoming Investor Conferences

February 21, 2025

From Lantheus Holdings, Inc.

Via GlobeNewswire

Despite its impressive fundamentals, NASDAQ:LNTH remains undervalued. ↗

February 21, 2025

Uncover the potential of LANTHEUS HOLDINGS INC, an undervalued stock. NASDAQ:LNTH maintains a strong financial position and offers an appealing valuation.

Via Chartmill

Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time

February 12, 2025

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting

February 05, 2025

From Lantheus Holdings, Inc.

Via GlobeNewswire

NASDAQ:LNTH is showing decent growth, but is still valued reasonably. ↗

January 31, 2025

LANTHEUS HOLDINGS INC was identified as an affordable growth stock. NASDAQ:LNTH is showing great growth, but also scores well on profitability. At the same time it seems to be priced reasonably.

Via Chartmill

Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member

January 30, 2025

From Lantheus Holdings, Inc.

Via GlobeNewswire

NASDAQ:LNTH is probably undervalued for the fundamentals it is displaying. ↗

January 30, 2025

LANTHEUS HOLDINGS INC has a stellar value proposition. NASDAQ:LNTH not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point.

Via Chartmill

Why Lantheus Holdings Stock Got Thrashed on Tuesday ↗

January 29, 2025

Via The Motley Fool

9 Health Care Stocks With Whale Alerts In Today's Session ↗

January 28, 2025

Via Benzinga

Lantheus To Buy Evergreen Theragnostics For Over $1 Billion To Bolster Its Cancer Radiopharmaceutical Portfolio ↗

January 28, 2025

Lantheus strengthens its radiopharmaceutical business with Evergreen and Life Molecular acquisitions, adding oncology and Alzheimer's diagnostics.

Via Benzinga

Why NASDAQ:LNTH Is a Standout High-Growth Stock in a Consolidation Phase. ↗

January 28, 2025

Based on a technical and fundamental analysis of NASDAQ:LNTH we ask: Is LANTHEUS HOLDINGS INC (NASDAQ:LNTH) on the Verge of a Major Breakout as a Strong Growth Stock?

Via Chartmill

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader

January 28, 2025

From Lantheus Holdings, Inc.

Via GlobeNewswire

Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt ↗

January 17, 2025

Deal opportunities abound: KKR & Co.'s stake in Maya; DuPont's electronics business; Ingevity's North Charleston site; and S&W Seed Company.

Via Benzinga

Topics Government

Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market

January 13, 2025

From Lantheus Holdings, Inc.

Via GlobeNewswire

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.